APO Research
Talk to an analyst

APO RESEARCH · REPORT

Antihelminthics

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Antihelminthics Industry Growth and Trends Forecast to 2032

19 December 2025107 pages

Choose your research edition.

Industry ResearchAntihelminthics Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Antihelminthics Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Antihelminthics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antihelminthics Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Antihelminthics Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Antihelminthics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Antihelminthics is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Antihelminthics is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Antihelminthics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Antihelminthics include Abbott, Sanofi, Sanofi, Johnson & Johnson, Novartis, Pfizer, GlaxoSmithKline, Bayer and AstraZeneca, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Antihelminthics market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Antihelminthics market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Antihelminthics market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Antihelminthics.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Antihelminthics market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Antihelminthics Market by Company

Abbott

Sanofi

Sanofi

Johnson & Johnson

Novartis

Pfizer

GlaxoSmithKline

Bayer

AstraZeneca

ZEISS International

Merck & Co.

Mentis Pharma

Astellas Pharma

ALLERGAN

Antihelminthics Segment by Type

Salicylanilides

Benzimidazoles

Praziquantel

Abamectin

Other

Antihelminthics Segment by Application

Ascariasis

Giardiasis

Fasciolasis

Filariasis

Angiostrongylosis

Schistosomiasis

Other

Antihelminthics Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antihelminthics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antihelminthics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antihelminthics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Antihelminthics manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Antihelminthics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Salicylanilides Table 2. Major Company of Benzimidazoles Table 3. Major Company of Praziquantel Table 4. Major Company of Abamectin Table 5. Major Company of Other Table 6. Global Antihelminthics Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Antihelminthics Sales by Type (2021-2026) & (K Units) Table 8. Global Antihelminthics Sales Market Share in Volume by Type (2021-2026) Table 9. Global Antihelminthics Sales by Type (2021-2026) & (US$ Million) Table 10. Global Antihelminthics Sales Market Share in Value by Type (2021-2026) Table 11. Global Antihelminthics Price by Type (2021-2026) & (US$/Unit) Table 12. Global Antihelminthics Sales by Type (2027-2032) & (K Units) Table 13. Global Antihelminthics Sales Market Share in Volume by Type (2027-2032) Table 14. Global Antihelminthics Sales by Type (2027-2032) & (US$ Million) Table 15. Global Antihelminthics Sales Market Share in Value by Type (2027-2032) Table 16. Global Antihelminthics Price by Type (2027-2032) & (US$/Unit) Table 17. North America Antihelminthics Sales by Type (2021-2026) & (K Units) Table 18. North America Antihelminthics Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Antihelminthics Sales by Type (2021-2026) & (K Units) Table 20. Europe Antihelminthics Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Antihelminthics Sales by Type (2021-2026) & (K Units) Table 22. Asia-Pacific Antihelminthics Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Antihelminthics Sales by Type (2021-2026) & (K Units) Table 24. Latin America Antihelminthics Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Antihelminthics Sales by Type (2021-2026) & (K Units) Table 26. Middle East and Africa Antihelminthics Sales by Type (2021-2026) & (US$ Million) Table 27. Antihelminthics Industry Trends Table 28. Antihelminthics Industry Drivers Table 29. Antihelminthics Industry Opportunities and Challenges Table 30. Antihelminthics Industry Restraints Table 31. Global Antihelminthics Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Antihelminthics Revenue Market Share by Company (2021-2026) Table 33. Global Antihelminthics Sales by Company (2021-2026) & (K Units) Table 34. Global Antihelminthics Sales Share by Company (2021-2026) Table 35. Global Antihelminthics Market Price by Company (2021-2026) & (US$/Unit) Table 36. Global Antihelminthics Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Antihelminthics Major Company Production Sites and Headquarters Table 38. Global Antihelminthics Company, Product Type & Application Table 39. Global Antihelminthics Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Antihelminthics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Antihelminthics Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Antihelminthics Sales by Region (2021-2026) & (K Units) Table 44. Global Antihelminthics Sales Market Share in Volume by Region (2021-2026) Table 45. Global Antihelminthics Sales by Region (2021-2026) & (US$ Million) Table 46. Global Antihelminthics Sales Market Share in Value by Region (2021-2026) Table 47. Global Antihelminthics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 48. Global Antihelminthics Sales by Region (2027-2032) & (K Units) Table 49. Global Antihelminthics Sales Market Share in Volume by Region (2027-2032) Table 50. Global Antihelminthics Sales by Region (2027-2032) & (US$ Million) Table 51. Global Antihelminthics Sales Market Share in Value by Region (2027-2032) Table 52. Global Antihelminthics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 53. Global Antihelminthics Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Antihelminthics Sales by Application (2021-2026) & (K Units) Table 55. Global Antihelminthics Sales Market Share in Volume by Application (2021-2026) Table 56. Global Antihelminthics Sales by Application (2021-2026) & (US$ Million) Table 57. Global Antihelminthics Sales Market Share in Value by Application (2021-2026) Table 58. Global Antihelminthics Price by Application (2021-2026) & (US$/Unit) Table 59. Global Antihelminthics Sales by Application (2027-2032) & (K Units) Table 60. Global Antihelminthics Sales Market Share in Volume by Application (2027-2032) Table 61. Global Antihelminthics Sales by Application (2027-2032) & (US$ Million) Table 62. Global Antihelminthics Sales Market Share in Value by Application (2027-2032) Table 63. Global Antihelminthics Price by Application (2027-2032) & (US$/Unit) Table 64. North America Antihelminthics Sales by Application (2021-2026) & (K Units) Table 65. North America Antihelminthics Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Antihelminthics Sales by Application (2021-2026) & (K Units) Table 67. Europe Antihelminthics Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Antihelminthics Sales by Application (2021-2026) & (K Units) Table 69. Asia-Pacific Antihelminthics Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Antihelminthics Sales by Application (2021-2026) & (K Units) Table 71. Latin America Antihelminthics Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Antihelminthics Sales by Application (2021-2026) & (K Units) Table 73. Middle East and Africa Antihelminthics Sales by Application (2021-2026) & (US$ Million) Table 74. Abbott Company Information Table 75. Abbott Business Overview Table 76. Abbott Antihelminthics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Abbott Antihelminthics Product Portfolio Table 78. Abbott Recent Development Table 79. Sanofi Company Information Table 80. Sanofi Business Overview Table 81. Sanofi Antihelminthics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Sanofi Antihelminthics Product Portfolio Table 83. Sanofi Recent Development Table 84. Sanofi Company Information Table 85. Sanofi Business Overview Table 86. Sanofi Antihelminthics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Sanofi Antihelminthics Product Portfolio Table 88. Sanofi Recent Development Table 89. Johnson & Johnson Company Information Table 90. Johnson & Johnson Business Overview Table 91. Johnson & Johnson Antihelminthics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Johnson & Johnson Antihelminthics Product Portfolio Table 93. Johnson & Johnson Recent Development Table 94. Novartis Company Information Table 95. Novartis Business Overview Table 96. Novartis Antihelminthics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Novartis Antihelminthics Product Portfolio Table 98. Novartis Recent Development Table 99. Pfizer Company Information Table 100. Pfizer Business Overview Table 101. Pfizer Antihelminthics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Pfizer Antihelminthics Product Portfolio Table 103. Pfizer Recent Development Table 104. GlaxoSmithKline Company Information Table 105. GlaxoSmithKline Business Overview Table 106. GlaxoSmithKline Antihelminthics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. GlaxoSmithKline Antihelminthics Product Portfolio Table 108. GlaxoSmithKline Recent Development Table 109. Bayer Company Information Table 110. Bayer Business Overview Table 111. Bayer Antihelminthics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Bayer Antihelminthics Product Portfolio Table 113. Bayer Recent Development Table 114. AstraZeneca Company Information Table 115. AstraZeneca Business Overview Table 116. AstraZeneca Antihelminthics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. AstraZeneca Antihelminthics Product Portfolio Table 118. AstraZeneca Recent Development Table 119. ZEISS International Company Information Table 120. ZEISS International Business Overview Table 121. ZEISS International Antihelminthics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. ZEISS International Antihelminthics Product Portfolio Table 123. ZEISS International Recent Development Table 124. Merck & Co. Company Information Table 125. Merck & Co. Business Overview Table 126. Merck & Co. Antihelminthics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Merck & Co. Antihelminthics Product Portfolio Table 128. Merck & Co. Recent Development Table 129. Mentis Pharma Company Information Table 130. Mentis Pharma Business Overview Table 131. Mentis Pharma Antihelminthics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. Mentis Pharma Antihelminthics Product Portfolio Table 133. Mentis Pharma Recent Development Table 134. Astellas Pharma Company Information Table 135. Astellas Pharma Business Overview Table 136. Astellas Pharma Antihelminthics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. Astellas Pharma Antihelminthics Product Portfolio Table 138. Astellas Pharma Recent Development Table 139. ALLERGAN Company Information Table 140. ALLERGAN Business Overview Table 141. ALLERGAN Antihelminthics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 142. ALLERGAN Antihelminthics Product Portfolio Table 143. ALLERGAN Recent Development Table 144. North America Antihelminthics Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 145. North America Antihelminthics Sales by Country (2021-2026) & (K Units) Table 146. North America Antihelminthics Sales Market Share by Country (2021-2026) Table 147. North America Antihelminthics Sales Forecast by Country (2027-2032) & (K Units) Table 148. North America Antihelminthics Sales Market Share Forecast by Country (2027-2032) Table 149. North America Antihelminthics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 150. North America Antihelminthics Market Size by Country (2021-2026) & (US$ Million) Table 151. North America Antihelminthics Market Share by Country (2021-2026) Table 152. North America Antihelminthics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 153. North America Antihelminthics Market Share Forecast by Country (2027-2032) Table 154. Europe Antihelminthics Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 155. Europe Antihelminthics Sales by Country (2021-2026) & (K Units) Table 156. Europe Antihelminthics Sales Market Share by Country (2021-2026) Table 157. Europe Antihelminthics Sales Forecast by Country (2027-2032) & (K Units) Table 158. Europe Antihelminthics Sales Market Share Forecast by Country (2027-2032) Table 159. Europe Antihelminthics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 160. Europe Antihelminthics Market Size by Country (2021-2026) & (US$ Million) Table 161. Europe Antihelminthics Market Share by Country (2021-2026) Table 162. Europe Antihelminthics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 163. Europe Antihelminthics Market Share Forecast by Country (2027-2032) Table 164. Asia-Pacific Antihelminthics Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 165. Asia-Pacific Antihelminthics Sales by Country (2021-2026) & (K Units) Table 166. Asia-Pacific Antihelminthics Sales Market Share by Country (2021-2026) Table 167. Asia-Pacific Antihelminthics Sales Forecast by Country (2027-2032) & (K Units) Table 168. Asia-Pacific Antihelminthics Sales Market Share Forecast by Country (2027-2032) Table 169. Asia-Pacific Antihelminthics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 170. Asia-Pacific Antihelminthics Market Size by Country (2021-2026) & (US$ Million) Table 171. Asia-Pacific Antihelminthics Market Share by Country (2021-2026) Table 172. Asia-Pacific Antihelminthics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 173. Asia-Pacific Antihelminthics Market Share Forecast by Country (2027-2032) Table 174. Latin America Antihelminthics Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 175. Latin America Antihelminthics Sales by Country (2021-2026) & (K Units) Table 176. Latin America Antihelminthics Sales Market Share by Country (2021-2026) Table 177. Latin America Antihelminthics Sales Forecast by Country (2027-2032) & (K Units) Table 178. Latin America Antihelminthics Sales Market Share Forecast by Country (2027-2032) Table 179. Latin America Antihelminthics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 180. Latin America Antihelminthics Market Size by Country (2021-2026) & (US$ Million) Table 181. Latin America Antihelminthics Market Share by Country (2021-2026) Table 182. Latin America Antihelminthics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 183. Latin America Antihelminthics Market Share Forecast by Country (2027-2032) Table 184. Middle East and Africa Antihelminthics Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 185. Middle East and Africa Antihelminthics Sales by Country (2021-2026) & (K Units) Table 186. Middle East and Africa Antihelminthics Sales Market Share by Country (2021-2026) Table 187. Middle East and Africa Antihelminthics Sales Forecast by Country (2027-2032) & (K Units) Table 188. Middle East and Africa Antihelminthics Sales Market Share Forecast by Country (2027-2032) Table 189. Middle East and Africa Antihelminthics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 190. Middle East and Africa Antihelminthics Market Size by Country (2021-2026) & (US$ Million) Table 191. Middle East and Africa Antihelminthics Market Share by Country (2021-2026) Table 192. Middle East and Africa Antihelminthics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 193. Middle East and Africa Antihelminthics Market Share Forecast by Country (2027-2032) Table 194. Key Raw Materials Table 195. Raw Materials Key Suppliers Table 196. Antihelminthics Distributors List Table 197. Antihelminthics Customers List Table 198. Research Programs/Design for This Report Table 199. Authors List of This Report Table 200. Secondary Sources Table 201. Primary Sources List of Figures Figure 1. Antihelminthics Image Figure 2. Global Antihelminthics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antihelminthics Market Size (2021-2032) & (US$ Million) Figure 4. Global Antihelminthics Sales (2021-2032) & (K Units) Figure 5. Salicylanilides Image Figure 6. Global Salicylanilides Sales YoY Growth (2021-2032) & (K Units) Figure 7. Benzimidazoles Image Figure 8. Global Benzimidazoles Sales YoY Growth (2021-2032) & (K Units) Figure 9. Praziquantel Image Figure 10. Global Praziquantel Sales YoY Growth (2021-2032) & (K Units) Figure 11. Abamectin Image Figure 12. Global Abamectin Sales YoY Growth (2021-2032) & (K Units) Figure 13. Other Image Figure 14. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 15. Global Antihelminthics Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Antihelminthics Market Share by Type 2025 VS 2032 Figure 17. North America Antihelminthics Sales Market Share in Volume by Type in 2025 Figure 18. North America Antihelminthics Sales Market Share in Value by Type in 2025 Figure 19. Europe Antihelminthics Sales Market Share in Volume by Type in 2025 Figure 20. Europe Antihelminthics Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Antihelminthics Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Antihelminthics Sales Market Share in Value by Type in 2025 Figure 23. Latin America Antihelminthics Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Antihelminthics Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Antihelminthics Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Antihelminthics Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Antihelminthics Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Ascariasis Image Figure 30. Global Ascariasis Sales YoY Growth (2021-2032) & (K Units) Figure 31. Giardiasis Image Figure 32. Global Giardiasis Sales YoY Growth (2021-2032) & (K Units) Figure 33. Fasciolasis Image Figure 34. Global Fasciolasis Sales YoY Growth (2021-2032) & (K Units) Figure 35. Filariasis Image Figure 36. Global Filariasis Sales YoY Growth (2021-2032) & (K Units) Figure 37. Angiostrongylosis Image Figure 38. Global Angiostrongylosis Sales YoY Growth (2021-2032) & (K Units) Figure 39. Schistosomiasis Image Figure 40. Global Schistosomiasis Sales YoY Growth (2021-2032) & (K Units) Figure 41. Other Image Figure 42. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 43. Global Antihelminthics Market Size Overview by Application (2021-2032) & (US$ Million) Figure 44. Global Antihelminthics Market Share by Application 2025 VS 2032 Figure 45. North America Antihelminthics Sales Market Share in Volume by Application in 2025 Figure 46. North America Antihelminthics Sales Market Share in Value by Application in 2025 Figure 47. Europe Antihelminthics Sales Market Share in Volume by Application in 2025 Figure 48. Europe Antihelminthics Sales Market Share in Value by Application in 2025 Figure 49. Asia-Pacific Antihelminthics Sales Market Share in Volume by Application in 2025 Figure 50. Asia-Pacific Antihelminthics Sales Market Share in Value by Application in 2025 Figure 51. Latin America Antihelminthics Sales Market Share in Volume by Application in 2025 Figure 52. Latin America Antihelminthics Sales Market Share in Value by Application in 2025 Figure 53. Middle East and Africa Antihelminthics Sales Market Share in Volume by Application in 2025 Figure 54. Middle East and Africa Antihelminthics Sales Market Share in Value by Application in 2025 Figure 55. North America Antihelminthics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. North America Antihelminthics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. North America Antihelminthics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. North America Antihelminthics Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Antihelminthics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Europe Antihelminthics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Antihelminthics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Europe Antihelminthics Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Antihelminthics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Asia-Pacific Antihelminthics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Asia-Pacific Antihelminthics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Asia-Pacific Antihelminthics Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Latin America Antihelminthics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 68. Latin America Antihelminthics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Latin America Antihelminthics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Latin America Antihelminthics Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. Middle East and Africa Antihelminthics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 72. Middle East and Africa Antihelminthics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 73. Middle East and Africa Antihelminthics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 74. Middle East and Africa Antihelminthics Market Share by Country: 2021 VS 2025 VS 2032 Figure 75. Antihelminthics Value Chain Figure 76. Key Raw Materials Price Figure 77. Manufacturing Cost Structure Figure 78. Antihelminthics Production Mode & Process Figure 79. Direct Comparison with Distribution Share Figure 80. Distributors Profiles Figure 81. Years Considered Figure 82. Research Process Figure 83. Key Executives Interviewed

Scope & coverage.

Types
  • Salicylanilides
  • Benzimidazoles
  • Praziquantel
  • Abamectin
  • Other
Applications
  • Ascariasis
  • Giardiasis
  • Fasciolasis
  • Filariasis
  • Angiostrongylosis
  • Schistosomiasis
  • Other
Companies covered
  • Abbott
  • Sanofi
  • Sanofi
  • Johnson & Johnson
  • Novartis
  • Pfizer
  • GlaxoSmithKline
  • Bayer
  • AstraZeneca
  • ZEISS International
  • Merck & Co.
  • Mentis Pharma
  • Astellas Pharma
  • ALLERGAN

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Antihelminthics Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Antihelminthics Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Antihelminthics Market by Type
  6. 1.3.1 Salicylanilides
  7. 1.3.2 Benzimidazoles
  8. 1.3.3 Praziquantel
  9. 1.3.4 Abamectin
  10. 1.3.5 Other
  11. 1.4 Global Antihelminthics Market Size by Type
  12. 1.4.1 Global Antihelminthics Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Antihelminthics Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Antihelminthics Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Antihelminthics Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Antihelminthics Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Antihelminthics Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Antihelminthics Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Antihelminthics Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Antihelminthics Industry Trends
  2. 2.2 Antihelminthics Industry Drivers
  3. 2.3 Antihelminthics Industry Opportunities and Challenges
  4. 2.4 Antihelminthics Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Antihelminthics Revenue (2021-2026)
  2. 3.2 Global Top Players by Antihelminthics Sales (2021-2026)
  3. 3.3 Global Top Players by Antihelminthics Price (2021-2026)
  4. 3.4 Global Antihelminthics Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Antihelminthics Major Company Production Sites & Headquarters
  6. 3.6 Global Antihelminthics Company, Product Type & Application
  7. 3.7 Global Antihelminthics Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Antihelminthics Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Antihelminthics Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Antihelminthics Tier 1, Tier 2, and Tier 3
4 Antihelminthics Regional Status and Outlook
  1. 4.1 Global Antihelminthics Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Antihelminthics Historic Market Size by Region
  3. 4.2.1 Global Antihelminthics Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Antihelminthics Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Antihelminthics Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Antihelminthics Forecasted Market Size by Region
  7. 4.3.1 Global Antihelminthics Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Antihelminthics Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Antihelminthics Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Antihelminthics by Application
  1. 5.1 Antihelminthics Market by Application
  2. 5.1.1 Ascariasis
  3. 5.1.2 Giardiasis
  4. 5.1.3 Fasciolasis
  5. 5.1.4 Filariasis
  6. 5.1.5 Angiostrongylosis
  7. 5.1.6 Schistosomiasis
  8. 5.1.7 Other
  9. 5.2 Global Antihelminthics Market Size by Application
  10. 5.2.1 Global Antihelminthics Market Size Overview by Application (2021-2032)
  11. 5.2.2 Global Antihelminthics Historic Market Size Review by Application (2021-2026)
  12. 5.2.3 Global Antihelminthics Forecasted Market Size by Application (2027-2032)
  13. 5.3 Key Regions Market Size by Application
  14. 5.3.1 North America Antihelminthics Sales Breakdown by Application (2021-2026)
  15. 5.3.2 Europe Antihelminthics Sales Breakdown by Application (2021-2026)
  16. 5.3.3 Asia-Pacific Antihelminthics Sales Breakdown by Application (2021-2026)
  17. 5.3.4 South America Antihelminthics Sales Breakdown by Application (2021-2026)
  18. 5.3.5 Middle East and Africa Antihelminthics Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Abbott
  2. 6.1.1 Abbott Company Information
  3. 6.1.2 Abbott Business Overview
  4. 6.1.3 Abbott Antihelminthics Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Abbott Antihelminthics Product Portfolio
  6. 6.1.5 Abbott Recent Developments
  7. 6.2 Sanofi
  8. 6.2.1 Sanofi Company Information
  9. 6.2.2 Sanofi Business Overview
  10. 6.2.3 Sanofi Antihelminthics Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sanofi Antihelminthics Product Portfolio
  12. 6.2.5 Sanofi Recent Developments
  13. 6.3 Sanofi
  14. 6.3.1 Sanofi Company Information
  15. 6.3.2 Sanofi Business Overview
  16. 6.3.3 Sanofi Antihelminthics Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Sanofi Antihelminthics Product Portfolio
  18. 6.3.5 Sanofi Recent Developments
  19. 6.4 Johnson & Johnson
  20. 6.4.1 Johnson & Johnson Company Information
  21. 6.4.2 Johnson & Johnson Business Overview
  22. 6.4.3 Johnson & Johnson Antihelminthics Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Johnson & Johnson Antihelminthics Product Portfolio
  24. 6.4.5 Johnson & Johnson Recent Developments
  25. 6.5 Novartis
  26. 6.5.1 Novartis Company Information
  27. 6.5.2 Novartis Business Overview
  28. 6.5.3 Novartis Antihelminthics Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Novartis Antihelminthics Product Portfolio
  30. 6.5.5 Novartis Recent Developments
  31. 6.6 Pfizer
  32. 6.6.1 Pfizer Company Information
  33. 6.6.2 Pfizer Business Overview
  34. 6.6.3 Pfizer Antihelminthics Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Pfizer Antihelminthics Product Portfolio
  36. 6.6.5 Pfizer Recent Developments
  37. 6.7 GlaxoSmithKline
  38. 6.7.1 GlaxoSmithKline Company Information
  39. 6.7.2 GlaxoSmithKline Business Overview
  40. 6.7.3 GlaxoSmithKline Antihelminthics Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 GlaxoSmithKline Antihelminthics Product Portfolio
  42. 6.7.5 GlaxoSmithKline Recent Developments
  43. 6.8 Bayer
  44. 6.8.1 Bayer Company Information
  45. 6.8.2 Bayer Business Overview
  46. 6.8.3 Bayer Antihelminthics Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Bayer Antihelminthics Product Portfolio
  48. 6.8.5 Bayer Recent Developments
  49. 6.9 AstraZeneca
  50. 6.9.1 AstraZeneca Company Information
  51. 6.9.2 AstraZeneca Business Overview
  52. 6.9.3 AstraZeneca Antihelminthics Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 AstraZeneca Antihelminthics Product Portfolio
  54. 6.9.5 AstraZeneca Recent Developments
  55. 6.10 ZEISS International
  56. 6.10.1 ZEISS International Company Information
  57. 6.10.2 ZEISS International Business Overview
  58. 6.10.3 ZEISS International Antihelminthics Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 ZEISS International Antihelminthics Product Portfolio
  60. 6.10.5 ZEISS International Recent Developments
  61. 6.11 Merck & Co.
  62. 6.11.1 Merck & Co. Company Information
  63. 6.11.2 Merck & Co. Business Overview
  64. 6.11.3 Merck & Co. Antihelminthics Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Merck & Co. Antihelminthics Product Portfolio
  66. 6.11.5 Merck & Co. Recent Developments
  67. 6.12 Mentis Pharma
  68. 6.12.1 Mentis Pharma Company Information
  69. 6.12.2 Mentis Pharma Business Overview
  70. 6.12.3 Mentis Pharma Antihelminthics Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Mentis Pharma Antihelminthics Product Portfolio
  72. 6.12.5 Mentis Pharma Recent Developments
  73. 6.13 Astellas Pharma
  74. 6.13.1 Astellas Pharma Company Information
  75. 6.13.2 Astellas Pharma Business Overview
  76. 6.13.3 Astellas Pharma Antihelminthics Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Astellas Pharma Antihelminthics Product Portfolio
  78. 6.13.5 Astellas Pharma Recent Developments
  79. 6.14 ALLERGAN
  80. 6.14.1 ALLERGAN Company Information
  81. 6.14.2 ALLERGAN Business Overview
  82. 6.14.3 ALLERGAN Antihelminthics Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 ALLERGAN Antihelminthics Product Portfolio
  84. 6.14.5 ALLERGAN Recent Developments
7 North America by Country
  1. 7.1 North America Antihelminthics Sales by Country
  2. 7.1.1 North America Antihelminthics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Antihelminthics Sales by Country (2021-2026)
  4. 7.1.3 North America Antihelminthics Sales Forecast by Country (2027-2032)
  5. 7.2 North America Antihelminthics Market Size by Country
  6. 7.2.1 North America Antihelminthics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Antihelminthics Market Size by Country (2021-2026)
  8. 7.2.3 North America Antihelminthics Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Antihelminthics Sales by Country
  2. 8.1.1 Europe Antihelminthics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Antihelminthics Sales by Country (2021-2026)
  4. 8.1.3 Europe Antihelminthics Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Antihelminthics Market Size by Country
  6. 8.2.1 Europe Antihelminthics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Antihelminthics Market Size by Country (2021-2026)
  8. 8.2.3 Europe Antihelminthics Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Antihelminthics Sales by Country
  2. 9.1.1 Asia-Pacific Antihelminthics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Antihelminthics Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Antihelminthics Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Antihelminthics Market Size by Country
  6. 9.2.1 Asia-Pacific Antihelminthics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Antihelminthics Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Antihelminthics Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Antihelminthics Sales by Country
  2. 10.1.1 South America Antihelminthics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Antihelminthics Sales by Country (2021-2026)
  4. 10.1.3 South America Antihelminthics Sales Forecast by Country (2027-2032)
  5. 10.2 South America Antihelminthics Market Size by Country
  6. 10.2.1 South America Antihelminthics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Antihelminthics Market Size by Country (2021-2026)
  8. 10.2.3 South America Antihelminthics Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Antihelminthics Sales by Country
  2. 11.1.1 Middle East and Africa Antihelminthics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Antihelminthics Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Antihelminthics Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Antihelminthics Market Size by Country
  6. 11.2.1 Middle East and Africa Antihelminthics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Antihelminthics Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Antihelminthics Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Antihelminthics Value Chain Analysis
  2. 12.1.1 Antihelminthics Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Antihelminthics Production Mode & Process
  7. 12.2 Antihelminthics Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Antihelminthics Distributors
  10. 12.2.3 Antihelminthics Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst